PIK3CA vascular overgrowth syndromes: an update
Authors:
- 1 August 2020
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Pediatrics
- Vol. 32 (4) , 539-546
Abstract
Purpose of review: Over the past decade many previously poorly understood vascular malformation disorders have been linked to somatic activating mutations in PIK3CA, which regulates cell survival and growth via activation of the mTOR1-AKT pathway. The goal of this article is to describe and provide an update on the clinical features, complications, and management strategies for the PIK3CA-related overgrowth spectrum (PROS). Recent findings: PROS encompasses a heterogenous group of disorders with complications related to the tissues harboring the mutation. Vascular malformation syndromes, such as Klippel–Trenaunay syndrome and Congenital Lipomatous Overgrowth Vascular malformations Epidermal nevi and Skeletal abnormalities, have an increased risk of thromboembolic complications, which is accentuated postprocedurally. Asymmetric overgrowth, particularly of limbs, results in a high rate of orthopedic complications. Hypoglycemia screening in the neonatal period and ongoing monitoring for growth failure is recommended in megalencephaly capillary malformation due to its association with multiple endocrinopathies. Recently, sirolimus, an mTOR1 inhibitor, has shown promise in vascular anomalies and now PROS. PIK3CA direct inhibitor, Alpelisib (BYL719), was recently trialed with significant clinical benefit. Summary: As the pathogenesis of these conditions is better elucidated and targeted treatments are developed, recognizing the clinical features, comorbidities, and evolving therapeutic landscape across the PROS spectrum becomes more crucial for optimization of care.Keywords
This publication has 52 references indexed in Scilit:
- CLOVES SyndromeThe Journal of Hand Surgery, 2013
- Diffuse capillary malformation with overgrowth: A clinical subtype of vascular anomalies with hypertrophyJournal of the American Academy of Dermatology, 2013
- Megalencephaly Syndromes and Activating Mutations in the PI3K‐AKT Pathway: MPPH and MCAPAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2013
- Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CANature Genetics, 2012
- De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromesNature Genetics, 2012
- Sirolimus for the treatment of complicated vascular anomalies in childrenPediatric Blood & Cancer, 2011
- The Misnomer “Macrocephaly–Cutis Marmorata Telangiectatica Congenita Syndrome”Archives of Dermatology, 2009
- Diagnostic criteria and tumor screening for individuals with isolated hemihyperplasiaGenetics in Medicine, 2009
- Klippel-Trénaunay syndrome: The importance of “geographic stains” in identifying lymphatic disease and risk of complicationsJournal of the American Academy of Dermatology, 2004
- Congenital infiltrating lipomatosis of the face with cerebral abnormalitiesEuropean Radiology, 2000